FIELD: medicine, medicinal microbiology.
SUBSTANCE: the innovation deals with detecting hemolytic activity (HA) and anti-hemoglobin activity (AntiHbA) of microorganisms isolated out of the focus of purulent-inflammatory disease. At HA values being above or equal to 70% hemolysis, and the AntiHbA value being above 3 g/l one should predict the development of anemia. Application of the present method enables to predict the development of anemia in patients with purulent-inflammatory diseases at improved efficiency.
EFFECT: higher accuracy and efficiency of prediction.
7 dwg, 4 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETERMINATION OF ANTI-HEMOGLOBIN ACTIVITY OF MICROORGANISMS | 2004 |
|
RU2262705C2 |
| METHOD FOR DIFFERENTIATING ENTEROCOCCI OF HUMAN INTESTINAL MICROFLORA | 2015 |
|
RU2575086C2 |
| METHOD FOR ESTIMATING ACTIVITY OF GLUCOSE-6-PHOSPHATE-DEHYDROGENASE IN ERYTHROCYTES | 0 |
|
SU1265614A1 |
| METHOD FOR TREATING PYOINFLAMMATORY SOFT TISSUE DISEASES OF MICROBIAL ETIOLOGY | 2005 |
|
RU2306947C2 |
| METHOD FOR PREDICTING RHINOTUBAL MICROORGANISM MIGRATION INTO TYMPANIC CAVITY IN UPPER AIRWAY DISEASES | 2005 |
|
RU2286574C1 |
| METHOD OF PROGNOSIS OF UNFAVORABLE COURSE OF SUPPURATIVE-INFLAMMATORY DISEASE OF MICROBIAL ETIOLOGY | 1995 |
|
RU2111493C1 |
| METHOD FOR PREDICTING THE FLOW OF PYODERMAS | 2004 |
|
RU2258220C1 |
| METHOD FOR PREDICTION OF DEGREE OF RISK OF HAEMOLYTIC COMPLICATIONS FOLLOWING CORONARY BYPASS SURGERY | 2013 |
|
RU2542434C1 |
| METHOD FOR DIFFERENTIATING HUMAN OLFACTORY MUCOSA STAPHYLOCOCCUS MICROFLORA | 2006 |
|
RU2318021C2 |
| METHOD FOR RESTORING HEMATOLOGICAL PARAMETERS IN DOGS | 2021 |
|
RU2758005C1 |
